Evidence map›Paper›PMID 27347690›Full record

ArticleInorganic chemistry2016

New Bifunctional Chelator p-SCN-PhPr-NE3TA for Copper-64: Synthesis, Peptidomimetic Conjugation, Radiolabeling, and Evaluation for PET Imaging.

Yongkang Gai, Lingyi Sun, Wenqi Hui, Qin Ouyang, Carolyn J Anderson, Guangya Xiang, Xiang Ma, Dexing Zeng

Abstract read
In one paragraph

Article in Inorganic chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography.European journal of nuclear medicine and molecular imaging · 2022
    Article
  4. Comparison of AlJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2020
    Article
  5. Evaluation of an Integrin αMolecular pharmaceutics · 2020
    Article
  6. Article
  7. Article
  8. PET and SPECT imaging of melanoma: the state of the art.European journal of nuclear medicine and molecular imaging · 2018
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yongkang GaiSchool of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology , 13 Hangkong Road, Wuhan 430030, China.
Lingyi SunDepartment of Radiology, University of Pittsburgh , Pittsburgh, Pennsylvania 15219, United States.
Wenqi HuiCollege of Pharmacy, The Third Military Medical University , Chongqing 400038, China.
Qin OuyangCollege of Pharmacy, The Third Military Medical University , Chongqing 400038, China.
Carolyn J AndersonDepartment of Radiology, University of Pittsburgh , Pittsburgh, Pennsylvania 15219, United States.
Guangya XiangSchool of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology , 13 Hangkong Road, Wuhan 430030, China.
Xiang MaSchool of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology , 13 Hangkong Road, Wuhan 430030, China.
Dexing ZengDepartment of Radiology, University of Pittsburgh , Pittsburgh, Pennsylvania 15219, United States.

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
Solid-Phase Platform for the Preparation of Dual-receptor Targeted PET AgentsR21EB017317 · NIBIB · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZENG, DEXING · 2013 to 2014
$415k
NCI NIH HHS P30 CA047904NIBIB NIH HHS R21 EB017317
6 · The paper itself

Abstract

Bifunctional chelators play an important role in developing metallic radionuclide-based radiopharmaceuticals. In this study, a new bifunctional ligand, p-SCN-PhPr-NE3TA, was synthesized and conjugated to a very late antigen-4 targeting peptidomimetic, LLP2A, for evaluating its application in (64)Cu-based positron emission tomography (PET) imaging. The new ligand exhibited strong selective coordination of Cu(II), leading to a robust Cu complex, even in the presence of 10-fold Fe(III). The LLP2A conjugate of p-SCN-PhPr-NE3TA was prepared and successfully labeled with (64)Cu under mild conditions. The conjugate (64)Cu-NE3TA-PEG4-LLP2A showed significantly higher specific activity, compared with (64)Cu-NOTA-PEG4-LLP2A, while maintaining comparable serum stability. Subsequent biodistribution studies and PET imaging in mice bearing B16F10 xenografts confirmed its favorable in vivo performance and high tumor uptake with low background, rendering p-SCN-PhPr-NE3TA a promising bifunctional chelator for (64)Cu-based radiopharmaceuticals.

Indexed as

Chelating AgentsCopper RadioisotopesMagnetic Resonance SpectroscopyPeptidomimeticsPositron-Emission TomographySpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationChelating AgentsCopper RadioisotopesPeptidomimetics

Identifiers

PMID27347690
PMCPMC4949121

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.